Study at a glance
How was vitamin D tested in mice with disrupted sleep?
Researchers divided 24 male mice into four groups. They compared normal conditions, 28 days of repeated sleep disruption, sleep disruption followed by recovery, and sleep disruption with vitamin D3. A moving cage bar disturbed the mice for ten hours each day. The researchers measured stress-related responses, immune cells and the gut.
What changed in mice given vitamin D during sleep disruption?
Mice given vitamin D moved more in one test than mice with sleep disruption alone. The proportions of selected immune-cell types changed. Two intestinal proteins and propionate, a substance made by gut bacteria, were higher. Several other behaviour, inflammation and clock-gene measurements did not differ clearly. Another bacterial substance, butyrate, did not increase clearly with vitamin D.
Did all the measured systems recover?
The findings were mixed. They do not show that all measured systems recovered. A stress-hormone response was clear within some groups but not others. That alone does not prove the groups responded differently to treatment. The study also did not establish that changes in the gut caused changes in hormones or behaviour.
Do these mouse findings show that vitamin D restores sleep?
Each group contained only six mice. Sleep duration and stages were not confirmed by recordings of brain activity. Blood vitamin D levels were not measured, and how the treatment was given and how often were unclear. The recovery group was assessed a week later. Some written claims disagreed with the figures. This experiment does not show that vitamin D restores sleep or treats sleep problems in people.
Read the full article below ↓A 24-mouse study found selective changes in stress-related, immune and gut measurements with vitamin D3 during repeated sleep disruption. Several other results were null, and some broad claims in the prose conflicted with the figures. The experiment does not establish improved human sleep or a normalised stress axis. For the detailed analysis, see Vitamin D3, Sleep Disruption and Stress-Immune-Gut Measurements: Full Study.
This is a VD3FL analysis of the complete principal paper and all 11 main figures. The supplementary DOCX was not available for independent checking. The account uses verified main-paper results and identifies material disagreements between the prose and plots.
The experiment
Four groups of six male mice underwent normal conditions, 28 days of mechanical sleep disruption, disruption followed by recovery, or disruption with vitamin D3. A cage bar moved once a minute for ten hours daily. No EEG confirmed sleep duration or stages, and the recovery group was assessed after an additional week.
The reported amount was 1,000 IU/kg, but route and frequency were not clearly specified in the inspected methods. Blood vitamin D status was not measured. This is not a human dosing instruction or evidence of correction of measured deficiency.
Which results were supported?
Vitamin D-treated mice showed more open-field movement than disrupted-sleep mice, changes in selected immune-cell proportions, higher ZO-1 and claudin protein expression, and higher propionate. These were separate measurements, not proof that every system improved.
Several behavioural outcomes, hypothalamic inflammatory transcripts and clock-gene treatment comparisons were nonsignificant. The Th1-to-Th2 ratio was not restored, and the vitamin D comparison did not significantly increase butyrate. This is a mixed pattern within Vitamin D and Inflammatory Signalling, rather than universal immune or inflammatory recovery.
The gut findings also need care. Relative abundance is not absolute bacterial growth, inferred microbial pathways are not measured metabolism, and the paper contains conflicts about diversity, family labels, LPS and the sample type used for short-chain fatty acids. The relationship to Vitamin D and Gut remains exploratory.
Why the stress-axis conclusion is limited
Dexamethasone suppression was significant within the normal and vitamin D groups but not within the disrupted group. That difference in significance does not establish a significant treatment difference between groups. Basal corticosterone did not differ significantly, and the caption’s stated statistical method does not match the repeated-animal sequence cleanly.
Consequently, the paper does not demonstrate complete restoration of HPA-axis function. The general feedback framework is described in Vitamin D and the HPA Axis. It also did not establish that gut changes caused the hormone or behavioural observations.
Conclusion
The verified findings support further investigation of selected responses to vitamin D3 in this small animal model. They do not establish restored sleep, a universal anti-inflammatory effect or a treatment for human sleep disruption. The principal paper’s 11 figures were examined; the additional supplement was unavailable.
Scientific sources
Wu CW, Huang YJ, Xu JW, et al. Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony. Brain and Behavior. 2025;15(11):e71084. DOI 10.1002/brb3.71084; PMID 41273001. Readable full text is available at PubMed Central.
Related reading
Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony
Chronic sleep desynchrony proliferates in modern society, characterized by extended wakefulness and disrupted circadian rhythms over a long period, and is associated with various physiological and immune dysfunctions.
Original paper ↗Read more →Vitamin D3, Sleep Disruption and Stress-Immune-Gut Measurements: Full Study
Detailed review of a mouse experiment on vitamin D3, sleep disruption and stress, immune and gut measurements, with mixed results and reporting limitations.
Read more →Researchers follow vitamin D and gut inflammation over 12 weeks
Medical News Today reported on changes in symptoms and immune markers among 48 adults with inflammatory bowel disease.
Read more →3′‐Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut‐Immune‐Cardiovascular Axis in LDLR −/− Mice
Herein, 40 male low‐density lipoprotein receptor knockout (LDLR −/−) mice were randomized into five groups: normal diet (ND), high‐cholesterol diet (HCD), and three 3′‐SL groups (low dose SLL, medium dose SLM, high dose SLH).
Original paper ↗Read more →Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial
This study investigated whether synbiotics could improve gut microbiota and systemic inflammation in lupus patients.
Original paper ↗Read more →Inflammation: and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells
Available drugs aim to suppress gut inflammation.
Original paper ↗Read more →Multi-omics analyses unveil gut microbiota and metabolites signatures in deoxycholic acid-associated intestinal inflammation
High-fat diet (HFD) is closely related to the increased incidence of inflammatory bowel disease (IBD), and excessive fecal deoxycholic acid (DCA) induced by HFD makes significant contribution to the colonic inflammation.
Original paper ↗Read more →Role of Increasing Body Mass Index in Gut Barrier Dysfunction, Systemic Inflammation, and Metabolic Dysregulation in Obesity
Results: The statistical analyses of the clinical parameters were based on the full sample set, whereas a subset composed of 37 randomized patients was inspected for the GC/MS metabolite profiling of fecal specimens.
Original paper ↗Read more →The association of Malnutrition-Inflammation Score with sleep quality and mental health in hemodialysis patients: a multicenter cross-sectional study
Therefore, the study aimed to investigate the association between the Malnutrition-Inflammation Score (MIS) and various health parameters, including sleep quality and mental health in hemodialysis patients.
Original paper ↗Read more →The Role of Vitamin D in Gastrointestinal Homeostasis and Gut Inflammation
Gastrointestinal homeostasis describes a delicate state of equilibrium in which various systems cooperate to maintain digestive health, support microbial activity, and regulate immune responses.
Original paper ↗Read more →Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway
Neutrophils significantly accumulate within the inflamed intestinal mucosa of patients with inflammatory bowel disease (IBD), where the farnesoid X receptor (FXR) is typically downregulated.
Original paper ↗Read more →Hydrogen Breath Test Dynamics Reflect Intestinal Fermentation Rather than Systemic Inflammation: A Data-Driven Diagnostic Analysis
This study evaluated the relationship between hydrogen production dynamics and systemic biomarkers using a data-driven analytical approach.
Original paper ↗Read more →Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
This study aimed to evaluate the incidence and risk factors for hypophosphataemia following intravenous ferric carboxymaltose (FCM) in patients with IBD.
Original paper ↗Read more →Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions
Rheumatoid arthritis is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint destruction.
Original paper ↗Read more →Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full Study
Examine vitamin D research on endothelial inflammatory signalling and immune-cell adhesion, with clear limits on what it establishes about cardiovascular risk.
Read more →Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Study Summary
A concise guide to endothelial inflammation and vitamin D: what cell experiments measure, where their findings differ, and why clinical benefit remains uncertain.
Read more →Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway
Environmental factors, including westernised diets and alterations to the gut microbiota, are considered risk factors for inflammatory bowel diseases (IBD).
Original paper ↗Read more →Probiotic Supplementation in Chronic Kidney Disease: Outcomes on Uremic Toxins, Inflammation, and Vascular Calcification from Experimental and Clinical Models
We aimed to evaluate the impact of a commercial probiotic (Probimel) supplementation on kidney function, mineral metabolism, inflammation and VC in both an experimental rat model and patients with advanced CKD and VC.
Original paper ↗Read more →Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation
Vitamin D receptor (VDR) deficiency contributes to the development of experimental inflammatory bowel disease (IBD) in several different models.
Original paper ↗Read more →Vitamin D, systemic inflammation, and motoric cognitive risk: exploring the risk factors and mediation pathways
Motoric cognitive risk (MCR) syndrome, defined by subjective cognitive complaints and slow gait, is a predementia condition associated with multiple adverse outcomes.
Original paper ↗Read more →Vitamins K2 and D3 Improve Long COVID, Fungal Translocation, and Inflammation: Randomized Controlled Trial
Objective and hypothesis: This trial aims to investigate the effects of vitamins K2/D3 on LC symptoms, as well as gut and inflammatory markers, in people with established long COVID.
Original paper ↗Read more →Original sources
Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony
Chronic sleep desynchrony proliferates in modern society, characterized by extended wakefulness and disrupted circadian rhythms over a long period, and is associated with various physiological and immune dysfunctions.
Publication details
Wu CW, Huang YJ, Xu JW, et al. Vitamin D3 Improves Hypothalamic-Pituitary-Adrenal Axis Function, Immunological Responses, and Gut Dysbiosis in Sleep Desynchrony. Brain and Behavior. 2025;15(11):e71084. DOI 10.1002/brb3.71084; PMID 41273001. Readable full text is available at PubMed Central.